Related Experiment Video
Updated: Mar 20, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Immunotherapy of Melanoma
Carolin Bender1, Jessica C Hassel, Alexander Enk
1Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Melanoma, a serious skin cancer, has seen improved treatments with immunotherapy and targeted therapies. This review explores current and future immunotherapeutic strategies, including novel combination treatments for advanced melanoma.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Melanoma is a malignant tumor originating from melanocytes.
- Advanced melanoma typically presents a poor prognosis and resistance to conventional therapies.
- Recent advancements include targeted therapy, immunotherapy, and adoptive T-cell therapy.
Purpose of the Study:
- To provide an overview of immunotherapeutic approaches for melanoma.
- To discuss the limitations of current melanoma treatments.
- To highlight novel combination agents in clinical trials for advanced melanoma.
Main Methods:
- Literature review of past, present, and future immunotherapeutic strategies.
- Focus on combination agents in early clinical trials.
- Analysis of treatment outcomes and limitations.
Main Results:
- Immunotherapy and targeted therapy have significantly improved advanced melanoma care.
- Existing treatments have limitations, necessitating further research.
- Combination therapies show promise in early-stage clinical trials.
Conclusions:
- Immunotherapy represents a paradigm shift in advanced melanoma treatment.
- Ongoing research focuses on overcoming treatment resistance and improving efficacy.
- Combination immunotherapeutic agents are a key area for future clinical development.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

